| INTRODUCTION
Alzheimer's disease (AD) is the most common cause of dementia, accounting for up to 75% of all cases (Mayeux & Stern, 2012; Qiu, Kivipelto, & Strauss, 2009) . Mutations in three genes have been identified in familial AD, encoding: amyloid precursor protein (APP), presenilin-1 (PS-1) and PS2 (Reitz & Mayeux, 2014) . Interestingly, these proteins are involved in the production of amyloid β-peptides (Aβ). This observation, and the description of Aβ toxicity, has led to the amyloid hypothesis for AD, which postulates that Aβ accumulation drives a cascade of events leading to progressive synaptic and neuronal dysfunction and, eventually, cell death (Hardy & Selkoe, 2002) . This hypothesis has been strongly challenged, however.
In particular, the role of mitochondrial dysfunction in the aetiology of AD is of increasing interest (Ankarcrona, Mangialasche, & Winblad, 2010) . Indeed, mitochondrial alterations have been described for many years in AD (Baloyannis, 2006; Bubber, Haroutunian, Fisch, Blass, & Gibson, 2005; Hirai et al., 2001) . In particular, defects in complex IV activity have been frequently reported (Cardoso, Santana, Swerdlow, & Oliveira, 2004; Cottrell, Borthwick, Johnson, Ince, & Turnbull, 2002; Kish et al., 1992; Parker & Parks, 1990; Parker, Filley, & Parks, 1995) . Nevertheless, the majority of these studies were performed in postmortem tissue from AD patients, or in a context where the clinical pathology was already apparent, thus not distinguishing between causal and consequential mitochondrial defects in AD.
Computational models are mathematical descriptions of the current state of knowledge, and have emerged as valuable tools in biology to enhance traditional hypothesis-based experimental approaches (Brodland, 2015) . In order to provide a holistic molecular interpretation of experimental data and further inform experimental design, we integrated a multilevel assessment of mitochondrial function (Connolly et al., 2017 ) in a cellular model of AD in the absence of overt Aβ toxicity (Ozmen, Albientz, Czech, & Jacobsen, 2009), with thorough analysis of a flux-based computational model of the mitochondrial respiratory chain (RC) (Beard, 2005; Huber, Dussmann, Kilbride, Rehm, & Prehn, 2011) .
| RESULTS

| Calibration of a flux-based computational model of the mitochondrial respiratory chain
We implemented a previously published (Beard, 2005; Huber et al., 2011) computational model of the mitochondrial RC that incorporates fluxes through the mitochondrial respiratory complexes, ATP production mediated by the F 1 F o ATP synthase, the mitochondrial membrane potential, and nucleotide, ion and proton fluxes across the mitochondrial membranes ( Figure 1a ). The model is described in detail in Methods and Supporting Information Appendix S1. We first parameterized the computational model using values from the literature (preferentially from wild-type (WT) primary neurons; see Supporting Information Tables S1-S4 
| Transgenic AD neurons have impaired mitochondrial respiratory capacity
Using a Seahorse XF Analyzer, we measured the oxygen consumption rate (OCR) in primary cortical neurons from both WT and B6.152H transgenic mice, a genetic model of AD (hereafter named transgenic AD [TgAD] mice). We performed the classical "mitochondrial stress test" protocol (Connolly et al., 2017; Figure 2a) . Interestingly, basal OCR, the OCR contributing to ATP synthesis (oligomycin-sensitive respiration) and the OCR consumed by H + leak (oligomycin-insensitive respiration) were similar in both WT and TgAD neurons (Figure 2b ,c). Maximum OCR induced by mitochondrial uncoupling (FCCP), however, was significantly lower in TgAD neurons (−24%, p = 0.003; Figure 2c ). Calculating additional bioenergetic metrics (Brand & Nicholls, 2011) , we observed that TgAD neurons also exhibited reduced spare capacity and cell respiratory control ratio (−47%, p = 1 × 10 −5 and −27%, p = 0.002, respectively; Figure 2c ).
| Computational analysis suggests a defect in NADH flux to the respiratory chain
We next utilized the computational model to investigate which molecular alterations could produce the observed respiratory Moreover, the size, number and total area of mitochondria were also similar in both genotypes (Figure 3e ), collectively demonstrating intact mitochondrial integrity, morphology and network dynamics.
To further assess activity of the respiratory chain, we investigated mitochondrial membrane potential (ΔΨ m ). The computational model predicted that, while impaired respiratory chain activity induces a measurable decrease in baseline ΔΨ m , a defect in NADH supply induces a smaller reduction (Figure 3f ). The model also predicted that such an impairment has a minimal effect on ΔΨ m fold changes in response to oligomycin, rotenone or antimycin A, but has a greater effect on the response to FCCP (Figure 3g ). To investigate these predictions experimentally, we measured ΔΨ m using TMRM.
We first measured baseline ΔΨ m by bathing neurons in a saline containing K-gluconate to depolarize the plasma membrane and remove the confounding effect of plasma membrane potential changes on TMRM fluorescence (Tottene, Moretti, & Pietrobon, 1996; Ward et al., 2007) . We did not measure a significant difference in baseline F I G U R E 2 Oxygraphy measurements in live cells show impairment of maximal respiration in transgenic AD neurons, and the computational model predicts that this can be explained by a defect in mitochondrial NADH flux. (a) The experimental protocol followed to measure the oxygen consumption rate (OCR) in primary cortical neurons. The classical "mitochondrial stress test" assesses mitochondrial respiratory activity: oligomycin (Oligo, 2 μg/ml) inhibits the F 1 F o ATP synthase, FCCP (0.5 μM) uncouples respiration, and antimycin A (AntiA; 1 μM) inhibits electron flow and abolishes mitochondrial respiration. Nonmitochondrial OCR (OCR remaining after addition of all drugs) is subtracted from all measurements to calculate the displayed OCR metrics (Brand & Nicholls, 2011) : basal = mitochondria-specific respiration at rest; ATP synthesis = basal OCR dedicated to ATP production (oligomycin-sensitive respiration); proton (H + ) leak = basal OCR uncoupled from ATP production (oligomycin-insensitive respiration); maximal OCR = OCR upon uncoupling of respiration from ATP production; spare capacity = "spare" OCR available while at rest ( To validate these predictions, we measured NAD(P)H autofluorescence in our primary cultures, using classical epifluorescence microscopy ( Figure 4b ). We note that simulated redox status (WTsim) agrees with NAD(P)H autofluorescence measurements in WT cells (Figure 4a ), a difference we did not detect via epifluorescence measurements. However, the low sensitivity of whole-cell autofluorescence measurements performed by epifluorescence microscopy may prevent the detection of smaller differences at baseline. We therefore sought to undertake a more sensitive measure of NAD(P)H.
| Transgenic AD neurons have reduced mitochondrial and glycolytic NAD(P)H concentration
To provide a more sensitive read-out of NAD(P)H steady-state levels, we next performed 2-photon fluorescence lifetime imaging microscopy (FLIM) of NAD(P)H autofluorescence. The lifetime of fluorescence emitted following excitation of NAD(P)H is distributed into two populations, a short lifetime (~0.5 ns) associated with free NAD(P)H, and a longer lifetime (~2.8 ns) associated with proteinbound, "active" NAD(P)H (Becker, 2015; Lakowicz, Szmacinski, Nowaczyk, & Johnson, 1992) . FLIM can therefore measure the proportion of free and bound NAD(P)H (Vergen et al., 2012) . Moreover, FLIM can also measure the overall amplitude of the NAD(P)H autofluorescence signal, independent of its lifetime, and is one of the most sensitive read-outs available to measure NAD ( (P)H levels in TgAD neurons (A1+A2, −35%, p = 0.005, Figure 5d ).
Using the spatial resolution of 2-photon microscopy to isolate the signal directly in the mitochondria, we also measured a significant decrease in mitochondrial NAD(P)H in TgAD neurons (−50%, p = 0.003, Figure 5e ). These data confirmed the predicted impairment in mitochondrial NAD(P)H homeostasis in TgAD neurons. No differences were seen between WT and TgAD neurons following induction of maximal NAD(P)H autofluorescence with oligomycin (Oligo; 2 μg/ml). Oligomycin indirectly inhibits NAD(P)H consumption by reducing respiratory chain activity. n (independent cultures-number of neurons): WT 5-37, TgAD 5-38. (d) Similarly, NAD(P)H autofluorescence levels after rotenone (Rot; 2 μM) did not differ between WT and TgAD neurons. Rotenone directly blocks NAD(P)H consumption through its inhibition of complex I. n: WT 5-38, TgAD 4-32. (e) Minimal NAD(P)H autofluorescence levels following FCCP addition (0.5 μM) did not differ between genotypes, but levels following subsequent rotenone addition (Rot, 2 μM) were significantly lower in TgAD neurons compared to WT (*p < 0.05). n: WT 4-20, TgAD 5-27. (f) Average NAD(P)H autofluorescence time-series traces enlarged from (d) (left) and rate of increase of autofluorescence signal following rotenone addition (right). The rate of increase was significantly slower in TgAD neurons (***p = 6 × 10 We combined OCR and ECAR measurements to calculate the contribution of glycolysis and mitochondrial oxidative phosphorylation to ATP production rates (Mookerjee & Brand, 2015; Mookerjee, Gerencser, Nicholls, & Brand, 2017) . Consistent with our previous data (Figure 5j To investigate the source of glycolytic impairment, we measured the expression levels of several rate-limiting enzymes and transporters associated with glucose metabolism-glucose transporter 3 (GLUT3), hexokinase 1 (HK1), lactate dehydrogenase (LDH) and mitochondrial pyruvate carriers 1 and 2 (MPC1-2). Interestingly, we did not observe any differences between the two genotypes (Figure 6f,g ), suggesting that a defect affecting glycolysis might originate from levels of regulation other than the expression levels of these proteins.
| Reduced mitochondrial NAD(P)H in transgenic AD neurons is caused by an impaired glycolytic flux
We further investigated the causal relationship between the glycolytic impairment and mitochondrial NAD(P)H flux reduction. In TgAD neurons, an impaired glycolytic flux, and the resultant reduction in cytosolic NAD(P)H and carbon fluxes to mitochondria, could lead to decreased import/production of NAD(P)H by mitochondria. In this case, we hypothesized that providing pyruvate, rather than glucose, to the neurons would bypass any glycolytic impairment and F I G U R E 6 Extracellular acidification rate (ECAR) measurements demonstrate a glycolytic defect in transgenic AD neurons, and experiments in pyruvate suggest a causal relationship between glycolytic and mitochondrial impairments. (a) Experimental protocol followed to measure the extracellular acidification rate (ECAR) in primary cortical neurons. Maximal glycolysis = ECAR after inhibition of F 1 F o ATP synthase activity with oligomycin (Oligo; 2 μg/ml). Glycolytic reserve (Glyc. reserve) = "spare" ECAR available while at rest (maximal-basal). (b) Basal ECAR and the oxygen consumption rate (OCR)/ECAR ratio in WT and transgenic AD (TgAD) neurons. TgAD neurons had significantly lower ECAR compared to WT, and were more aerobic (higher OCR/ECAR ratio). *p < 0.05, ***p < 0.001. n (independent cultures-number of wells): WT 10-134, TgAD 12-120. (c) Maximal glycolysis (Max. glyc.) and glycolytic reserve were also significantly lower in TgAD transgenic neurons (**p < 0.01, ***p < 0.001). n: WT 5-44, TgAD 7-51. (d) Proportion of glycolytic (black) and oxidative (grey) ATP production in basal conditions. (e) Glycolytic, oxidative and total ATP production in basal conditions and following oligomycin addition (+Oligo; 2 μg/ml), normalized to WT basal levels. (d, e) **p < 0.01; ***p < 0.001. n: WT 10-73, TgAD 12-76. (f) Representative Western blots with molecular weight markings to the right of the blots, and (g) corresponding densitometry analysis of proteins involved in glucose metabolism-glucose transporter 3 (GLUT3; n (independent cultures): WT 5, TgAD 7), hexokinase 1 (HK1), lactate dehydrogenase (LDH), mitochondrial pyruvate carriers 1/2 (MPC1/2) (all n: WT 4, TgAD 4). Actin or HSP90 were used as loading controls. Black vertical lines indicate where some blots were cut to remove the molecular weight marker. (h-k) Measurements in WT and TgAD neurons supplemented with 5 mM pyruvate. (h) Basal OCR, proton leak, ATP synthesis and maximal OCR, as described in Figure 2a restore mitochondrial health. We therefore repeated key experiments in which we observed significant differences compared to WT neurons, supplementing neurons with pyruvate (5 mM) rather than glucose. Interestingly, this ablated all significant NAD(P)H impairments measured in TgAD neurons (Figure 6h-k) . As bypassing glycolysis suppressed mitochondrial defects in TgAD neurons, this indicated that a glycolytic defect may be primarily responsible for the mitochondrial NAD(P)H dyshomeostasis observed in these cells.
| DISCUSSION
In this study, we utilized an interdisciplinary experimental and computational approach and found that primary cortical neurons from a transgenic AD mouse model have impaired glycolytic flux, reduced (Clerc & Polster, 2012; Pike Winer & Wu, 2014; Zeidler et al., 2017) , and maximal respiration specifically (Gouarne et al., 2013; Tan, Xiao, Li, Zeng, & Yin, 2015) -further validating the strong link between glucose metabolism and mitochondrial activity.
Both our experimental and computational analyses argued against a direct impairment of the mitochondrial RC in TgAD neurons. Although impairments in RC activity, specifically in complex IV, have been frequently associated with AD (Bosetti et al., 2002; Kish et al., 1992; ; Rhein et al., 2009; Yao et al., 2009 ), findings are not wholly consistent (Choi et al., 2012; Kipanyula et al., 2012) , and studies were primarily performed in postmortem AD brains or in situations where clinical pathology was already apparent. In these instances, RC impairments may be related to Aβ toxicity (Pagani & Eckert, 2011) . In our TgAD mice (B6.152H), elevated Aβ deposits have been detected in the brain at 3-6 months of age, with decreased complex IV activity and cognitive defects evident at 8 months (Ozmen et al., 2009; ; Rhein et al., 2009; Richards et al., 2003) . Thus, it is noteworthy that the bioenergetic impairments reported here were identified in primary cortical neurons prepared from pups prior to any increased Aβ production/deposition or the onset of pathological behavioural phenotypes. These results further suggest a mechanism outside amyloid considerations for the bioenergetic impairment described here.
Our work, demonstrating glucose hypometabolism in vitro, echoes clinical research in humans, with glucose metabolism of increasing importance in AD research. Indeed, impaired glucose metabolism is one of the most reliable indicators of disease progression, potentially preceding clinical symptoms by years or even decades (Bubber et al., 2005; Chen & Zhong, 2013) . However, the molecular mechanisms linking glycolysis defects to neurodegeneration remain elusive, with contrasting findings on the level of glucose metabolism enzymes and transporters in AD patients (Bigl, Bruckner, Arendt, Bigl, & Eschrich, 1999; Harr, Simonian, & Hyman, 1995) , and animal models of AD (Zhu, Shan, Yuzwa, & Vocadlo, 2014) , and inhibition of a glycoside hydrolase prevented cognitive decline, plaque formation and tau aggregates in transgenic mouse models of neurodegeneration (Hastings et al., 2017; Yuzwa et al., 2014) . On this aspect, however, studies in appropriate neuronal models are lacking. Moreover, dysregulated Ca 2+ signalling, as previously described in these TgAD neurons (Kipanyula et al., 2012) , could also affect glucose/NAD(P)H metabolism (Llorente-Folch et al., 2015; Pancani, Anderson, Porter, & Thibault, 2011) , and Wnt signalling was recently suggested as a potential link between neuronal physiology, glucose metabolism and AD (Cisternas & Inestrosa, 2017 
| Primary cultures of cortical neurons
Primary neuronal cultures were obtained from cortices dissected from 0-to 1-day newborn mice of either sex, as previously described (Kipanyula et al., 2012) . Experiments were performed after 9-11 days in vitro (DIV) unless stated otherwise.
| TMRM and NAD(P)H epifluorescence microscopy
Experiments were performed following the standardized protocols described recently (Connolly et al., 2017) . After verifying signal stability, baseline measurements were used to normalize the traces. We utilized a combination of mitochondrial inhibitors to assess the impact on mitochondrial membrane potential (ΔΨ m ) and NAD(P)H, and therefore investigate ΔΨ m and NADH fluxes (Connolly et al., 2017) . To measure baseline ΔΨ m , we bathed neurons in a saline containing 130 mM K-gluconate to dissipate the plasma membrane potential (ΔΨ p ) and overcome the confounding effect of baseline ΔΨ p changes on TMRM fluorescence (Tottene et al., 1996; Ward et al., 2007) . Drug concentrations are listed in Supporting Information Table S5 .
| Oxygraphy, extracellular acidification measurements and ATP calculations
Live OCR and extracellular acidification rate (ECAR) were measured simultaneously using a Seahorse XFe24 Analyzer (Agilent). Saline and equilibration conditions were the same as for live imaging. The classical "mitochondrial stress test" protocol was performed as previously described (Connolly et al., 2017) . After calculation of the buffering power of the experimental saline and the proton rate production (Mookerjee & Brand, 2015) , mitochondrial and cytosolic (glycolytic) ATP production rates were calculated from OCR and ECAR measurements as described previously (Mookerjee et al., 2017) .
| Immunofluorescence and transfection
Transfection of a mitochondria-targeted red fluorescent protein DsRed (mtDsRed), cloned in a pcDNA3 backbone (Filadi et al., 2015) , was performed the day after plating, 6 hr before the change from plating medium to growth medium, with Lipofectamine 2000 (Thermo Fisher), following the protocol provided by the manufacturer. Fixation and immunofluorescence were performed as previously described (Filadi et al., 2015) . Primary antibodies directed against GFAP and NF200 are detailed in Supporting Information Table S6 .
| 2-photon NAD(P)H fluorescence lifetime imaging microscopy (FLIM)
Neurons were equilibrated at 37°C in the same saline as for NAD(P)H autofluorescence experiments, and imaging was performed at 22°C in the same saline with pH adjusted for temperature. FLIM measurements were carried out using the time-correlated single-photon counting (TCSPC) method. Amplitude (A1, A2) and fluorescence lifetime (τ 1 , τ 2 ) parameters were extracted from the decay fitting.
| Protein extraction and Western blotting
For extraction and denaturation of proteins, two different protocols were used: RC complexes, MPC1 and 2 and GLUT3 were extracted in RIPA buffer and denatured at 55°C; HK1 and LDH were extracted in Tris-HCl and denatured at 70°C. After extraction, proteins were quantified using the BCA Protein Assay Kit (Pierce) following the manufacturer's instructions. Detection of proteins was performed by chemiluminescence. The intensity of the bands was analysed using the Fiji software program.
| Morphological characterization of the mitochondrial network
Labelled mitochondria with a mitochondria-targeted red fluorescent protein (mtDsRed) were morphologically analysed as described in Koopman et al. (2005) using the Fiji software (Schindelin et al., 2012) .
| Computational modelling
The core computational model was originally developed as a selfcontained thermodynamically balanced model of oxidative phosphorylation and the electron transport chain, based on experimental observations in isolated cardiac mitochondria (Beard, 2005) . It has been compared to, and validated by, experimental data from in vitro cardiac and liver isolated mitochondria and in vivo skeletal muscle mitochondria (Bazil, Beard, & Vinnakota, 2016; Dash & Beard, 2008; Wu, Yang, Vinnakota, & Beard, 2007) , and was extended (additional flux incorporated to describe cytosolic ATP processes) to analyse respiratory chain function in intact cancer cells (Huber, Connolly, Dussmann, & Prehn, 2012; Huber et al., 2011) . We chose to implement this model (Figure 1a ) to specifically focus our computational investigations on the mitochondrial respiratory chain, impairments of which have been extensively reported in AD (Bosetti et al., 2002; Kish et al., 1992; Rhein et al., 2009; Yao et al., 2009 Data points outside this range are marked by "+." Differences between medians were determined using a rank sum test (MATLAB, The MathWorks). In all figures, * indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001. To determine whether differences predicted by simulated impairments might be experimentally measured, we set a threshold using statistical power analysis (dashed lines in Figure 2d ; see Supporting Information Appendix S1).
